New report on Memory Services from MSNAP 

The Royal College of Psychiatrists Memory Services National Accreditation Programme (MSNAP) have published their 2023 report which highlights data they’ve collected from memory clinics who are current members MSNAP. The report includes both quantitative and thematic analysis and provides some thought-provoking headlines, not least that the number of new admissions taken on by memory clinics per week has risen by 130% since 2009.  

Dr Sujoy Mukherjee, MSNAP Accreditation Committee Chair, said in foreword to the report: 
“Assessment and treatment of memory disorders are currently in a crossroad with new developments in treatment and assessment process. This will have major implications on how memory services are delivered in the UK over coming years. MSNAP is fully committed to remain and evolve at the cutting edge of assessing and improving quality in the future.”    

You can read the report here: https://www.rcpsych.ac.uk/docs/default-source/improving-care/ccqi/quality-networks/memory-clinics-msnap/msnap-national-report-(2023)2400cc4f-9e00-46ee-a132-5e834740f770.pdf   

MSNAP presented a webinar for Dementia Community on 28th November 2023, and you can find out more about their work here: https://youtu.be/Hj1QhYyFGLM 

Similar Posts

  • NICE publish final draft guidance on lecanemab and donanemab 

    Further to The National Institute for Health and Care Excellence (NICE) publishing draft guidance for public consultation about Alzheimer’s treatments donanemab and lecanemab (that we reported on here: https://journalofdementiacare.co.uk/nice-publish-further-draft-guidance-on-lecanemab-and-donanemab), NICE has published final draft guidance that continues to not recommend donanemab and lecanemab for use on the NHS.    Explaining the decision, Helen Knight, NICE Director…

  • Target Healthcare REIT: Dr Amanda Thompsell

    The Journal of Dementia Care is delighted that one of our Advisory Board members, Dr Amanda Thompsell, has been appointed by Target Healthcare REIT as an independent non-executive director. Dr Thompsell has practised as a GP, before switching to working in old age hospital medicine, and then retraining in old age psychiatry. She has significant…

  • App launched to help detect UTIs

    Newfoundland Diagnostics have collaborated with the Rightdose Self-Test and Treat App to provide an at-home test and treat service for those who test positive for urinary tract infections (UTIs).  The process for patients involves ordering a UTI test, then using the QR code on the box to download and register with the Rightdose Test and…

  • MHRA licence lecanemab for use in the UK

    NICE publish draft guidance not recommending it for NHS use  One of the new generation of drugs to treat Alzheimer’s disease, lecanemab, has been licenced by the Medicines and Healthcare products Regulatory Agency (MHRA) for prescription by doctors in Britain.  Read more about the MHRA decision here: https://www.gov.uk/government/news/lecanemab-licensed-for-adult-patients-in-the-early-stages-of-alzheimers-disease  National Institute for Health and Care Excellence…

  • ‘Nobody really knows us’

    A new report from Parkinson’s UK – Nobody really knows us – has found that the health and social care system is failing to meet the needs of people with Parkinson’s-related dementia. Carers are struggling to cope due to a lack of support, and little or no guidance on how to support their loved one when they experience…

  • Integrated care

    Better ways to integrate primary and community care will be explored by a House of Lords committee, which has issued a call for evidence on the challenges facing the sector and the barriers to integration. Chaired by Baroness Pitkeathley, the committee will look at existing models of integration, including the role of primary care networks…